Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

2.7K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.7K
Stress Prevention and Stress Management Techniques IV01:26

Stress Prevention and Stress Management Techniques IV

54
Stress often leads to unhealthy habits like smoking, excessive drinking, and overeating, which offer short-term relief but ultimately increase long-term health risks. These behaviors create a cycle that temporarily lowers stress levels but can result in severe long-term health consequences. Breaking these habits is essential to reduce the risk of chronic diseases and improve overall well-being. Three primary changes that support better health include quitting smoking, reducing alcohol intake,...
54
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

22
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
22
CNS Depressants: Alcohol and Nicotine01:27

CNS Depressants: Alcohol and Nicotine

327
Ethanol, a clear colorless alcohol, has been consumed by humans for millennia, but its effects on the body are far from benign. At lower doses, it induces decreased inhibitions and loquaciousness, leading to its social appeal. However, it can cause severe consequences at higher doses, such as coma and respiratory depression, due to its zero-order elimination kinetics. Chronic ethanol abuse wreaks havoc on multiple organ systems, particularly the CNS and the liver. Abrupt cessation of ethanol...
327
Drug Dependence01:17

Drug Dependence

1.1K
Medications are typically administered to achieve therapeutic effects. Some drugs can modify an individual's mood and perception, frequently resulting in various enjoyable experiences. However, this can result in drug dependency, a condition marked by continuous drug use despite potential negative consequences. Drug dependency primarily falls into two categories: psychological and physical dependence. Psychological dependence occurs when the pleasurable feelings induced by the drug...
1.1K
COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

277
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
277

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Continuous External Fetal Heart Rate Monitoring During Labor.

American family physician·2026
Same author

Vitamin D for Prevention of Disease: Guidelines From the Endocrine Society.

American family physician·2026
Same author

Vaccine fatigue and influenza vaccination trends across Pre-, Peri-, and Post-COVID-19 periods in the United States using epic's cosmos database.

PloS one·2025
Same author

Hair Loss: Diagnosis and Treatment.

American family physician·2024
Same author

Depression: Managing Resistance and Partial Response to Treatment.

American family physician·2024
Same author

Caring for Transgender and Gender-Diverse People: Guidelines From WPATH.

American family physician·2024

Related Experiment Video

Updated: Aug 21, 2025

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
06:39

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements

Published on: August 28, 2017

14.4K

Smoking Cessation Interventions.

Heidi L Gaddey1, MaryAnn Dakkak2, Nicole Marie Jackson2

  • 1Department of Family Medicine, Christie Clinic, Champaign, Illinois.

American Family Physician
|November 15, 2022
PubMed
Summary
This summary is machine-generated.

Smoking cessation is crucial for preventing disease and death. Evidence-based treatments, including extended pharmacotherapy, significantly improve quit rates and reduce relapse for tobacco users.

More Related Videos

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
09:25

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Published on: January 10, 2015

11.5K
Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
06:07

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

6.7K

Related Experiment Videos

Last Updated: Aug 21, 2025

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements
06:39

Electroencephalographic, Heart Rate, and Galvanic Skin Response Assessment for an Advertising Perception Study: Application to Antismoking Public Service Announcements

Published on: August 28, 2017

14.4K
Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations
09:25

Methods to Evaluate Cytotoxicity and Immunosuppression of Combustible Tobacco Product Preparations

Published on: January 10, 2015

11.5K
Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System
06:07

Cigarette Smoke Exposure in Mice using a Whole-Body Inhalation System

Published on: October 22, 2020

6.7K

Area of Science:

  • Public Health
  • Clinical Medicine
  • Addiction Medicine

Background:

  • Cigarette smoking remains a leading cause of preventable death in the U.S., with high relapse rates among those attempting to quit without support.
  • Despite known health risks, approximately 20% of U.S. adults use tobacco products, highlighting a significant public health challenge.

Purpose of the Study:

  • To review evidence-based smoking cessation strategies for all patient populations, including adolescents.
  • To emphasize the importance of integrating pharmacotherapy with behavioral interventions for improved outcomes.
  • To discuss the role of extended controller therapy and lung cancer screening in smoking cessation efforts.

Main Methods:

  • Review of clinical studies on smoking cessation interventions.
  • Analysis of the effectiveness of pharmacotherapies approved by the U.S. Food and Drug Administration (FDA).
  • Evaluation of the 5 A's framework (ask, advise, assess, assist, arrange) for clinical application.

Main Results:

  • Combining pharmacotherapy with behavioral strategies is more effective than either alone.
  • Extended use (over 12 weeks) of controller therapies (varenicline, bupropion, nicotine patch) shows higher sustained quit rates and lower relapse rates.
  • e-Cigarettes lack FDA approval for cessation, with inconclusive supporting evidence.

Conclusions:

  • All patients, including youth, should be screened for tobacco use and offered evidence-based cessation support.
  • Clinicians should utilize the 5 A's framework and consider extended pharmacotherapy for sustained smoking cessation.
  • Lung cancer screening in high-risk individuals should be integrated with smoking cessation interventions.